Vera Therapeutics (VERA) Other Working Capital Changes (2020 - 2026)
Vera Therapeutics posted quarterly Other Working Capital Changes of -$182000.0 for Q1 2026, down 103.1% year-on-year from $5.9 million in Q1 2025, and down 148.92% on a QoQ basis from $372000.0 in Q4 2025.
Vera Therapeutics (VERA) has 7 years of Other Working Capital Changes data on file, last reported at -$182000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 103.1% year-over-year to -$182000.0; the trailing twelve-month figure through Mar 2026 stood at -$2.1 million (down 147.3% YoY), and the FY2025 full-year result was $3.9 million, up 500.41% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$182000.0, down from $372000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $7.7 million in Q3 2022 and bottomed at -$6.7 million in Q2 2025.
- The 5-year median for Other Working Capital Changes is $303000.0 (2022), against an average of $488352.9.
- Peak annual rise in Other Working Capital Changes reached 1398.98% in 2025, while the deepest fall reached 1527.78% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at $482000.0 in 2022, then slumped by 234.65% to -$649000.0 in 2023, then surged by 238.21% to $897000.0 in 2024, then slumped by 58.53% to $372000.0 in 2025, then slumped by 148.92% to -$182000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$182000.0 (Q1 2026), $372000.0 (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -182,000.00 |
| Mar 31, 2026 | -182,000.00 |
| Dec 31, 2025 | 372,000.00 |
| Dec 31, 2025 | 372,000.00 |
| Sep 30, 2025 | 4.42 Mn |
| Sep 30, 2025 | 4.42 Mn |
| Jun 30, 2025 | -6.74 Mn |
| Jun 30, 2025 | -6.74 Mn |
| Mar 31, 2025 | 5.88 Mn |
| Mar 31, 2025 | 5.88 Mn |
| Dec 31, 2024 | 897,000.00 |
| Dec 31, 2024 | 897,000.00 |
| Sep 30, 2024 | -1.86 Mn |
| Sep 30, 2024 | -1.86 Mn |
| Jun 30, 2024 | -414,000.00 |
| Jun 30, 2024 | -414,000.00 |
| Mar 31, 2024 | 392,000.00 |
| Mar 31, 2024 | 392,000.00 |
| Dec 31, 2023 | -649,000.00 |
| Dec 31, 2023 | -649,000.00 |
| Sep 30, 2023 | -2.27 Mn |
| Sep 30, 2023 | -2.27 Mn |
| Jun 30, 2023 | 954,000.00 |
| Jun 30, 2023 | 954,000.00 |
| Mar 31, 2023 | -680,000.00 |
| Mar 31, 2023 | -680,000.00 |
| Dec 31, 2022 | 482,000.00 |
| Dec 31, 2022 | 482,000.00 |
| Sep 30, 2022 | 7.67 Mn |
| Sep 30, 2022 | 7.67 Mn |
| Jun 30, 2022 | 303,000.00 |
| Jun 30, 2022 | 303,000.00 |
| Mar 31, 2022 | -271,000.00 |
| Mar 31, 2022 | -271,000.00 |
| Dec 31, 2021 | -3.01 Mn |
| Dec 31, 2021 | -3.01 Mn |
| Sep 30, 2021 | 3.01 Mn |
| Sep 30, 2021 | 3.01 Mn |
| Jun 30, 2021 | -127,000.00 |
| Jun 30, 2021 | -127,000.00 |
| Mar 31, 2021 | 127,000.00 |
| Mar 31, 2021 | 127,000.00 |
| Dec 31, 2020 | -65,000.00 |
| Dec 31, 2020 | -65,000.00 |
| Sep 30, 2020 | -142,000.00 |
| Sep 30, 2020 | -142,000.00 |
| Jun 30, 2020 | 36,000.00 |
| Jun 30, 2020 | 36,000.00 |
| Mar 31, 2020 | 112,000.00 |
| Mar 31, 2020 | 112,000.00 |